Founded in 1923 and publicly traded under NYSE: WST, West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services and helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. The company's major products include containment solutions, prefillable systems, reconstitution and transfer systems, drug delivery systems, primary packaging, cartridge systems and components and specialty components, and it also offers contract manufacturing and analytical lab services.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support its customers by delivering over 41 billion components and devices each year. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue).
Recent Leadership News
- Michel Lagarde appointed next CEO, June 2026.
Facts compiled by Executive Moves from publicly available news and press releases on 2 June 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the West Pharmaceutical Services, Inc. team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
